Vijay Shreedhar
2020
In 2020, Vijay Shreedhar earned a total compensation of $842.3K as Chief Commercial Officer at Adamas Pharmaceuticals, a 32% decrease compared to previous year.
Compensation breakdown
| Bonus | $21,700 |
|---|---|
| Non-Equity Incentive Plan | $224,600 |
| Option Awards | $64,367 |
| Salary | $418,034 |
| Stock Awards | $55,100 |
| Other | $58,498 |
| Total | $842,299 |
Shreedhar received $418K in salary, accounting for 50% of the total pay in 2020.
Shreedhar also received $21.7K in bonus, $224.6K in non-equity incentive plan, $64.4K in option awards, $55.1K in stock awards and $58.5K in other compensation.
Rankings
In 2020, Vijay Shreedhar's compensation ranked 9,291st out of 13,090 executives tracked by ExecPay. In other words, Shreedhar earned more than 29.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,291 out of 13,090 | 29th |
Division Manufacturing | 3,967 out of 5,621 | 29th |
Major group Chemicals And Allied Products | 1,611 out of 2,254 | 29th |
Industry group Drugs | 1,409 out of 1,954 | 28th |
Industry Pharmaceutical Preparations | 1,033 out of 1,459 | 29th |
Source: SEC filing on April 19, 2021.
Shreedhar's colleagues
We found two more compensation records of executives who worked with Vijay Shreedhar at Adamas Pharmaceuticals in 2020.